Tailored prophylaxis in children with severe hemophilia: A four-year Iranian study
- 5 July 2021
- journal article
- research article
- Published by Elsevier BV in Transfusion and Apheresis Science
- Vol. 60 (6), 103212
- https://doi.org/10.1016/j.transci.2021.103212
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Hemophilia in IranHematology, 2016
- Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970sBlood, 2013
- New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor developmentHaemophilia, 2010
- Devising a best practice approach to prophylaxis in boys with severe haemophilia: evaluation of current treatment strategiesHaemophilia, 2010
- Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort studyBlood, 2007
- Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis StudyJournal of Thrombosis and Haemostasis, 2006
- Environmental risk factors for inhibitor development in children with haemophilia A: a case–control studyBritish Journal of Haematology, 2005
- A prospective, longitudinal study of central venous catheter‐related deep venous thrombosis in boys with hemophiliaJournal of Thrombosis and Haemostasis, 2004
- A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centresHaemophilia, 2003
- Experience of prophylaxis treatment in children with severe haemophiliaHaemophilia, 2002